| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.06▲ | 1.06▲ | 1.06▲ | 1.04▲ | 1.14▼ |
| MA10 | 1.08▼ | 1.08▼ | 1.08▼ | 1.07▼ | 1.27▼ |
| MA20 | 1.11▼ | 1.11▼ | 1.12▼ | 1.15▼ | 1.39▼ |
| MA50 | 1.15▼ | 1.17▼ | 1.18▼ | 1.30▼ | 1.85▼ |
| MA100 | 1.20▼ | 1.23▼ | 1.26▼ | 1.42▼ | 2.03▼ |
| MA200 | 1.26▼ | 1.33▼ | 1.36▼ | 1.81▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.003▼ | -0.004▼ | -0.004▼ | -0.021▼ |
| RSI | 38.892▼ | 38.740▼ | 38.268▼ | 34.718▼ | 33.620▼ |
| STOCH | 18.687▼ | 18.056▼ | 14.370▼ | 23.101 | 8.288▼ |
| WILL %R | -73.077 | -73.077 | -74.074 | -66.667 | -85.714▼ |
| CCI | -59.452 | -59.494 | -71.151 | -59.750 | -158.009▼ |
|
Thursday, September 03, 2026 07:54 AM
ImmunityBio looks attractive due to ANKTIVA's FDA approval for BCG-unresponsive NMIBC and pipeline expansion potential. See why I rate IBRX stock a Buy.
|
|
Wednesday, June 03, 2026 04:00 AM
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
|
|
Monday, May 18, 2026 07:34 AM
Shares of ImmunityBio (NASDAQ:IBRX) gained 4.5% in premarket trading on Monday after the company announced the issuance of five U.S. patents tied to its ANKTIVA plus BCG therapy for bladder cancer ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/10/26 | 1.07 | 1.07 | 1.0321 | 1.05 | 3,020 |
| 08/10/26 | 0.99 | 1.06 | 0.95 | 1.045 | 30,596 |
| 07/10/26 | 1.03 | 1.0352 | 0.9701 | 0.9907 | 22,921 |
| 06/10/26 | 1.03 | 1.07 | 1.025 | 1.05 | 6,787 |
| 05/10/26 | 1.04 | 1.0899 | 1.0304 | 1.05 | 17,273 |
| 02/10/26 | 1.09 | 1.09 | 1.01 | 1.01 | 14,728 |
| 01/10/26 | 1.12 | 1.12 | 1.07 | 1.1186 | 44,894 |
| 30/09/26 | 1.145 | 1.1747 | 1.12 | 1.12 | 5,733 |
| 29/09/26 | 1.145 | 1.16 | 1.13 | 1.145 | 6,839 |
| 28/09/26 | 1.14 | 1.15 | 1.10 | 1.15 | 19,913 |
|
|
||||
|
|
||||
|
|